Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-14

Clinical Trial Update: Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing safety and maintenance of effect of ziprasidone plus a mood stabilizer in bipolar I disorder (manic or mixed) completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Mania, Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-12-14